The benefits of providing benefit information: Examining the effectiveness of provision of simple benefit statements on people's judgements about a medicine

Psychology and Health

Volumn 22, Issue 1, 2007, Pages 61-82

  Bersellini, Elisabetta ^a   Berry, Dianne ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b Whiteknights House   (United Kingdom)

Author keywords

Compliance with medication; Medication benefits; Medicines information; Risk to health; Side effects

Indexed keywords

EID: 33845389088     PISSN: 08870446     EISSN: 14768321     Source Type: Journal    
DOI: 10.1080/14768320600603596     Document Type: Article

References (29)

1. Amery, W. K. (1999). Coming full circle in pharmacovigilance: Communicating safety information to patients through Patient Package Inserts. Pharmacoepidemiology & Drug Safety, 8, 121-129.
2. Azjen, I. (1988). Attitudes, personality and behaviour. Milton Keynes: Open University Press.
3. Berry, D. C., Knapp, P., & Raynor, D. K. (2002a). Provision of information about drug side-effects to patients. The Lancet, 359, 853-854.
4. Berry, D. C., Michas, I. C., & Bersellini, E. (2002b). Communicating information about medication side effects: Effects on satisfaction, perceived risk to health and intention to comply. Psychology and Health, 17, 247-267.
5. Berry, D. C., Michas, I. C., & Bersellini, E. (2003a). Communicating information about medicine: The benefits of making it personal. Psychology and Health, 18, 127-139.
6. Berry, D. C., Raynor, D. K., Knapp, P. R., & Bersellini (2003b). Patient understanding of risk: impact of EU Guidelines and other risk scales for consumer medicines information. Drug Safety, 26, 1-11.
7. Berry, D. C., Michas, I. C., Gillie, T., & Forster, M. (1997). What do patients want to know about their medicines and what do doctors want to tell them? A comparative study. Psychology and Health, 12, 467-480.
8. Bersellini, E., & Berry, D. C. (2004). Communicating information about medicines: The benefits of a benefit statement. Proceedings of the British Psychological Society, 2, 35.
9. Bogardus Jr, S. T., Holmboe, E., & Jekel, J. F. (1999). Perils, pitfalls, and possibilities in talking about medical risk. Journal of the American Medical Association, 281, 1037-1041.
10. Carrigan, N., Gardner, P. H., Conner, M., & Maule, J. (2004). The impact of structuring information in a patient decision aid. Psychology and Health, 19, 457-477.
11. Conner, M., & Norman, P. (2005). Predicting health behaviour: Research and practice with social cognition models (2nd Edn). Buckingham: Open University Press.
12. Coulter, A. Entwistle, V., & Gilbert, D. (1998). Informing patients: An assessment of the quality of patient information materials. London: King's Fund.
13. Cuervo, L. G., & Aronson, J. K. (2004). The road to health care. British Medical Journal, 329, 1-2.
14. Donovan, J. L., & Blake, D. R. (1992). Patient non-compliance: Deviance or reasoned decision-making? Social Science and Medicine, 34, 507-513.
15. European Commission (1992). EEC Directive 92/27/EEC on labelling of medicinal products for human use and on package leaflets (OJ No. L113 of 30 April 1992).
16. European Commission (1998). A guideline on the readability of the label and package leaflet of medicinal products for human use. EC Pharmaceuticals Committee.
17. Knapp, P., Raynor, D. K., & Berry, D. C. (2004). Comparison of two methods of presenting risk information to patients about the side effects of medicines. Quality & Safety in Healthcare, 13, 176-180.
18. Miller, L. G., Liu, H., Hays, R. D., Golin, C. E., Zhishen, Y., Beck, K., et al. (2003). Knowledge of antiretroviral regimen dosing and adherence: A longitudinal study. Clinical Infectious Diseases, 36, 514-518.
19. Mottram, D. R., & Reed, C. (1997). Comparative evaluation of patient information leaflets by pharmacists, doctors and the general public. Journal of Clinical Pharmacy Therapy, 22, 127-134.
20. Rogers, R. W. (1975). A protection motivation theory of fear appeals and attitude change. Journal of Psychology, 91, 93-114.
21. Rogers, R. W. (1983). Cognitive and physiological processes in fear appeals and attitude change. A revised theory of protection motivation. In J. R. Cacioppo & R. E. Petty (Eds), Social psychology: A source book. New York: Guildford Press.
22. Rosenstock, I. M. (1966). Why people use health services. Millbank Memorial Foundation Quarterly, 44, 94-124.
23. Rosenstock, I. M. (1974). The health belief model and preventative health behaviour. Health education monographs, 2, 354-356.
24. Sheeran, P. (2002). Intention-behaviour relations: A conceptual and empirical review. In W. Stroebe & M. Hewstone (Eds), European review of social psychology (pp. 1-36). Chichester: Wiley.
25. Sutton, S. (1998). Predicting and explaining intentions and behavior: How well are we doing? Journal of Applied Social Psychology, 28, 1317-1338.
26. Sutton, S. (2002). Using social cognition models to develop health behaviours and interventions: Problems and assumptions. In D. Rutter & L. Quine (Eds), Changing health behaviour: Intervention and research with social cognition models. Milton Keynes: Open University Press.
27. Vander Stichele, R. H., Vandierendonck, A., DeVooght, G., Reynvoet, B., & Lammerlyn, J. (2002). Impact of benefit messages in Patient Package Inserts on subjective drag perception. Drug Information Journal, 36, 201-208.
28. Waller, P., & Lee, F. (1999). Responding to drug safety issues. Pharmacoepidemobgical Drug Safety, 8, 535-552.
29. Ziegler, D. K., Moiser, M. G., Buenaver, M., & Okuyemi, K. (2001). How much information about adverse effects of medications do patients want from physicians? Archives of Internal Medicine, 161, 706-713.